Press Release: Edgemont Pharmaceuticals : Research and Markets: General Anxiety Disorder Therapeutics Pipeline Review, H1 2015 Featuring Edgemont Pharmaceuticals, LLC, H. Lundbeck A/S & Pfizer Inc.

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/3l3g27/general_anxiety) has announced the addition of the "General Anxiety Disorder - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for General Anxiety Disorder, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule